Acta Scientific Gastrointestinal Disorders (ISSN: 2582-1091)

Editorial Volume 3 Issue 6

100% Sustained Viral Response with Combination of Direct Acting Antiviral Therapy in Patient on Long Term Hemodialysis

Bouzegaou Hassiba*, Zenai El-Hadj Mehdi, Zaoui Mustapha, Benhlima Mohamed and Sassi Souad

Specialist Doctor in Gastroenterology and Digestive Endoscopy, Oran Wilaya, Oran Province, Algeria

*Corresponding Author: Bouzegaou Hassiba, Specialist Doctor in Gastroenterology and Digestive Endoscopy, Oran Wilaya, Oran Province, Algeria.

Received: April 09, 2020; Published: May 02, 2020

×

Abstract

 HCV is highly prevalent among patients on long term hemodialysis and is associated with poor prognosis; recently the emergence of combination of DAA has shown strong safety, efficacy and tolerability in treatment of HCV infection in hemodialysis patients.

×

References

×

Citation

Citation: Bouzegaou Hassiba., et al. “100% Sustained Viral Response with Combination of Direct Acting Antiviral Therapy in Patient on Long Term Hemodialysis”. Acta Scientific Gastrointestinal Disorders 3.6 (2020): 01.



Member In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 15, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US